Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 90,000 shares at $76.83 ($6.8M) on 2014-03-14, disclosed to the SEC on 2014-03-18.
Scheduled sale ($6.8M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.36 | 38,812 | $2.9M | 42.8% |
| 2 | $76.25 | 48,488 | $3.7M | 54.1% |
| 3 | $76.83 | 2,700 | $207K | 3.0% |
| Total | $75.88 avg | 90,000 | $6.8M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |